SUBJECTS | CREDITS |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
3(3-0) | |
2(2-0) | |
3(3-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
Total | 22 (20-2) |
SUBJECTS | CREDITS |
2(2-0) | |
2(2-0) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
Identification and Separation of Active Pharmaceutical Ingredients | 2(2-0) |
Identification and Separation of Active Pharmaceutical Ingredients practice | 1(0-1) |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
Total | 22 (16-6) |
SUBJECTS | CREDITS |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
Pharmacotherapy of Immunology, Haematology and Oncology Disorder | 2(2-0) |
2(2-0) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
Formulation and Technology of Liquid and Semisolid Dosage Forms | 2(2-0) |
Formulation and Technology of Liquid and Semisolid Dosage Forms practice | 1(0-1) |
Total | 20 (16-4) |
SUBJECTS | CREDITS |
2(2-0) | |
1(0-1) | |
2(2-0) | |
2(2-0) | |
Pharmacotherapy Gastrointestinal and Nutritional Theraphy Disorders | 2(2-0) |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
Total | 20 (16-4) |
SUBJECTS | CREDITS |
2(2-0) | |
1(0-1) | |
2(2-0) | |
3(3-0) | |
3(3-0) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
1(0-1) | |
3(3-0) | |
Total | 20 (17-3) |
SUBJECTS | CREDITS |
2(2-0) | |
2(2-0) | |
2(2-0) | |
1(0-1) | |
3(3-0) | |
2(2-0) | |
1(0-1) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
1(0-1) | |
Total | 20 (17-3) |
SUBJECTS | CREDITS |
Compulsory Courses:*) | |
4(0-4) | |
Elective courses:*) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
Total | 18 (14-4)* |
*) 4 Credits from compulsory and 14 credits from elective courses
SUBJECTS | CREDITS |
1(0-1) | |
1(0-1) | |
2(2-0) | |
2(2-0) | |
2(2-0) | |
Total | 8 (6-2) |